Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kevin Garofalo"'
Lost in hostile lands: moths of conservation concern in cultivated and suburban areas of south Italy
Publikováno v:
Nature Conservation, Vol 54, Iss , Pp 203-215 (2023)
Cultivated and suburban areas are usually considered unfavourable to the vulnerable components of biodiversity and regarded as not interesting from a conservation point of view. However, remnants of semi-natural vegetation can be embedded in such are
Externí odkaz:
https://doaj.org/article/e33678c075544ed785e3c10cd39fc219
Autor:
Josephine S D'Alessandro, Jay Duffner, Joel Pradines, Ishan Capila, Kevin Garofalo, Ganesh Kaundinya, Benjamin M Greenberg, Daniel Kantor, Tanmoy C Ganguly
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140299 (2015)
Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relapsing forms of multiple sclerosis. Gene expression profiling was performed as a means to evaluate equivalence of Glatopa and Copaxone®. Microarray an
Externí odkaz:
https://doaj.org/article/63deef62565443cb90ed61c31404d6bb
Autor:
Ganesh Kaundinya, Ishan Capila, Kevin Garofalo, Josephine D D`Alessandro, Daniel Kantor, Christopher M. Honan, Tanmoy Ganguly, Jay Duffner, Ian Fier, Ganlin Zhao
Publikováno v:
CNS & Neurological Disorders Drug Targets
Background: In April 2015, the US Food and Drug Administration approved the first generic glatiramer acetate, Glatopa® (M356), as fully substitutable for Copaxone® 20 mg/mL for relapsing forms of multiple sclerosis (MS). This approval was accomplis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637cc3e53ec6d92292ad7988c5a59b2e
http://europepmc.org/articles/PMC5684786
http://europepmc.org/articles/PMC5684786
Autor:
Laura Rutitzky, Daniel F. Ortiz, Jonathan C. Lansing, Julia Brown, Joseph Paquette, Kevin Garofalo, Josephine D'Alessandro, Naveen Bhatnagar, Maurice Hains, Abhinav Gupta, Stan Lee, Radouane Zouaoui, Jason Wang, John Schaeck, Salvatore Marchese, Robin Meccariello, Nathaniel Washburn, Kimberly Holte, Carlos J. Bosques, Anthony M. Manning
Publikováno v:
Cancer Research. 79:3244-3244
Numerous therapeutic monoclonal antibodies (mAbs) rely on antibody-dependent cell cytotoxicity (ADCC), antibody-dependent cell phagocytosis (ADCP) and complement-dependent cytotoxicity (CDC) Fc effector functions to deplete target cells and achieve c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf0c014a499f281c36f74e93ab3210ff
https://doi.org/10.1158/1538-7445.am2019-3244
https://doi.org/10.1158/1538-7445.am2019-3244
Autor:
Jonathan C. Lansing, Anthony M. Manning, Amit Choudhury, Edward Cochran, Jason K. Wang, Shannon Argueta, Kevin Garofalo, Abhinav Gupta, Naveen Bhatnagar, Carlos J. Bosques, Daniel Ortiz, Stan Lee, Viraj Parge, Karunya Srinivasan, Utsav Jetley, Jay Duffner, Danice Wilkins, Radouane Zouaoui
Publikováno v:
Cancer Research. 79:561-561
CD38 targeting antibodies are at different phases of clinical development, with daratumumab already approved as monotherapy and in combination with standards of care in multiple myeloma (MM). Anti-CD38 monoclonal antibodies (mAbs) induce tumor cell d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83f7c53612798a558fb19d4896b6641d
https://doi.org/10.1158/1538-7445.am2019-561
https://doi.org/10.1158/1538-7445.am2019-561
Autor:
Arnold von Eckardstein, Matthew P. Frosch, Ho-Joon Lee, Thorsten Hornemann, Robert H. Brown, Kevin Garofalo, Brian P. Schmidt, Florian Eichler, Anke Penno
Publikováno v:
Journal of Clinical Investigation. 121:4735-4745
Hereditary sensory and autonomic neuropathy type 1 (HSAN1) causes sensory loss that predominantly affects the lower limbs, often preceded by hyperpathia and spontaneous shooting or lancinating pain. It is caused by several missense mutations in the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::429eddde9b3921de42e9ab90d60a8d0e
https://doi.org/10.1172/jci57549
https://doi.org/10.1172/jci57549
Autor:
Robert H. Brown, Anke Penno, Thorsten Hornemann, Florian Eichler, Lohit Kini, Ho-Joon Lee, Ken Gable, Guiman Guan, Kevin Garofalo, Arnold von Eckardstein, Clifford J. Woolf, Martin K. Selig, Matthew P. Frosch, Alex Mccampbell, Eric Tamrazian, Daniel Vardeh, Jeffrey M. Harmon, Teresa M. Dunn, Dika Kuljis
Publikováno v:
The Journal of Neuroscience. 29:14646-14651
Mutations in the SPTLC1 subunit of serine palmitoyltransferase (SPT) cause an adult-onset, hereditary sensory, and autonomic neuropathy type I (HSAN1). We previously reported that mice bearing a transgene-expressing mutant SPTLC1 (tgSPTLC1C133W) show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c5cb3616befcb2b119c650c6a7df6ea
https://doi.org/10.1523/jneurosci.2536-09.2009
https://doi.org/10.1523/jneurosci.2536-09.2009
Autor:
Steven Tyler, Leona E. Ling, Jonathan C. Lansing, Laura I. Rutitzky, Hetal Sarvaiya, Amy Medeiros, Daniel Ortiz, Naveen Bhatnagar, Kevin Garofalo, Falk Nimmerjahn, Edward Cochran, Carlos J. Bosques, Nathaniel Washburn, Anthony M. Manning, Robin Meccariello, William Avery, Birgit Schultes, James Meador, Inessa Schwab, Divya J. Mekala, Ganesh Kaundinya
Publikováno v:
Proceedings of the National Academy of Sciences. 112
Despite the beneficial therapeutic effects of intravenous immunoglobulin (IVIg) in inflammatory diseases, consistent therapeutic efficacy and potency remain major limitations for patients and physicians using IVIg. These limitations have stimulated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a93fdeadc93b03126a40f1d4dfb6624
https://doi.org/10.1073/pnas.1422481112
https://doi.org/10.1073/pnas.1422481112
Autor:
Benjamin Greenberg, Ishan Capila, Ganesh Kaundinya, Daniel Kantor, Jay Duffner, Joel Pradines, Tanmoy Ganguly, Josephine S. D'alessandro, Kevin Garofalo
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140299 (2015)
PloS one, vol 10, iss 10
PLoS ONE
PloS one, vol 10, iss 10
PLoS ONE
Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relapsing forms of multiple sclerosis. Gene expression profiling was performed as a means to evaluate equivalence of Glatopa and Copaxone®. Microarray an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1cc517db76bfe48b80ee6e75740f52
http://europepmc.org/articles/PMC4608686?pdf=render
http://europepmc.org/articles/PMC4608686?pdf=render